Beskrivelse
Krav
Fullmektig i Norge:
Fullmektig i EP:
2015.08.19, US 201562207164 P
BRUCE A. KERWIN: "Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways", DISSOLUTION PROFILE OF NOVEL COMPOSITE PELLET CORES BASED ON DIFFERENT RATIOS OF MICROCRYSTALLINE CELLULOSE AND ISOMALT, vol. 97, no. 8, 1 August 2008 (2008-08-01), pages 2924 - 2935, XP055015864, ISSN: 0022-3549, DOI: 10.1002/jps.21190 (B1)
HA E ET AL: "PEROXIDE FORMATION IN POLYSORBATE 80 AND PROTEIN STABILITY", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 91, no. 10, 1 October 2002 (2002-10-01), pages 2252 - 2264, XP001148131, ISSN: 0022-3549, DOI: 10.1002/JPS.10216 (B1)
MEERA AGARKHED ET AL: "Effect of Polysorbate 80 Concentration on Thermal and Photostability of a Monoclonal Antibody", AAPS PHARMSCITECH, vol. 14, no. 1, 14 November 2012 (2012-11-14), pages 1 - 9, XP055350741, DOI: 10.1208/s12249-012-9878-0 (B1)
NAOTO INOUE ET AL: "Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 117, no. 5, 1 May 2014 (2014-05-01), pages 539 - 543, XP055135662, ISSN: 1389-1723, DOI: 10.1016/j.jbiosc.2013.10.016 (B1)
WO-A2-2009/100309 (B1)
SHARMA V K ET AL: "The fomulation and delivery of monoclonal antibodies", 1 January 2009, THERAPEUTIC MONOCLONAL ANTIBODIES : FROM BENCH TO CLINIC, WILEY, HOBOKEN, NJ, PAGE(S) 675 - 711, ISBN: 978-0-470-11791-0, XP009143115 (B1)
SZYMCZYK KATARZYNA ET AL: "Aggregation behavior of Triton X-114 and Tween 80 at various temperatures and concentrations studied by density and viscosity measurements", JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, KLUWER, DORDRECHT, NL, vol. 126, no. 1, 5 July 2016 (2016-07-05), pages 315 - 326, XP036052597, ISSN: 1388-6150, [retrieved on 20160705], DOI: 10.1007/S10973-016-5631-3 (B1)
US-A1- 2014 127 227 (B1)
WANG W ET AL: "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 96, no. 1, 1 January 2007 (2007-01-01), pages 1 - 26, XP009084505, ISSN: 0022-3549, DOI: 10.1002/JPS.20727 (B1)
NAOTO INOUE ET AL: "Specific Decrease in Solution Viscosity of Antibodies by Arginine for Therapeutic Formulations", MOLECULAR PHARMACEUTICS, vol. 11, no. 6, 2 June 2014 (2014-06-02), pages 1889 - 1896, XP055134481, ISSN: 1543-8384, DOI: 10.1021/mp5000218 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3769781)
|
Utgående
EP Registreringsbrev (3210) (PTEP3769781)
|
Innkommende, AR556600041
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 9. avg. år (EP) | 2024.08.09 | 3710 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2023.08.28 | 2550 | RWS TRANSLATIONS LIMITED | Betalt og godkjent |
32307167 expand_more expand_less | 2023.06.16 | 5580 | RWS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
Gebyr ved bruk av MasterCard-kort
80 = 80 X 1
|